TRIP13 and central nervous system cancer: Stratification of patient tumors based on the malignancy of gliomas informed us that the higher level of methylation of TRIP13 was identified in lower-grade glioma and had better outcomes as well, possibly attributed to the downregulation of DNA repair capacity and replication of tumor cells as a result of KEGG pathway enriched analysis.